case_images: PMC6501223_01
case_images: Initial axial PET scan (a) and CT scan (b) demonstrating hyperactivity along the left lateral tongue ((a) white arrow; (b) blue arrow).
case_images: CRIOT2019-9581259.001.jpg
case_images: PMC6501223_01_CRIOT2019-9581259.001.jpg
case_images: fig1
case_images: Radiographical findings on positron emission tomography (PET) scan showed hyperactivity along the left lateral aspect of the tongue and a mildly hypermetabolic left level IIa cervical lymph node with no evidence of distant metastases (Figure 1).
case_images: Axial PET scans revealing a new left apical pleural mass (white arrow) (a) and cardiac metastasis (blue arrow) (b).
case_images: CRIOT2019-9581259.002.jpg
case_images: PMC6501223_01_CRIOT2019-9581259.002.jpg
case_images: fig2
case_images: In early 2018, a PET scan (Figure 2) and magnetic resonance imaging (MRI) of the chest (Figure 3) showed a new 3.4 cm left apical pleural mass encasing the left subclavian artery and abutting the left subclavian vein, both of which were patent. A PET/CT scan demonstrated hypermetabolic lesions in the left neck, right thigh muscles, lung parenchyma, heart, anterior mediastinum, left scapula, and posterior right rib (Figure 2).
case_images: MRI of the chest demonstrating a new left apical pleural mass (white arrow).
case_images: CRIOT2019-9581259.003.jpg
case_images: PMC6501223_01_CRIOT2019-9581259.003.jpg
case_images: fig3
case_images: In early 2018, a PET scan (Figure 2) and magnetic resonance imaging (MRI) of the chest (Figure 3) showed a new 3.4 cm left apical pleural mass encasing the left subclavian artery and abutting the left subclavian vein, both of which were patent.
case_images: Cardiac MRI demonstrating a new mass infiltrating the left ventricular inferior myocardium, epicardial fat, and pericardium (blue arrow and red arrow).
case_images: CRIOT2019-9581259.004.jpg
case_images: PMC6501223_01_CRIOT2019-9581259.004.jpg
case_images: fig4
case_images: Further diagnostic imaging with a cardiac MRI was performed, which revealed a mass infiltrating the left ventricle, inferior myocardium, epicardial fat, and pericardium with associated mobile thrombus formation (Figure 4).